Translating the Promise of 5HT4 Receptor Agonists for the Treatment of Depression

Psychological Medicine - United Kingdom
doi 10.1017/s0033291720000604
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Thrombopoietin Receptor Agonists for the Treatment of Inherited Thrombocytopenia

Haematologica
Hematology
2020English

The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia

European Oncology and Haematology
OncologyHematology
2011English

Imidazole-Derived Agonists for the Neurotensin 1 Receptor

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2014English

The Continued Promise of Neuroprotection for Acute Stroke Treatment

Journal of Experimental Stroke and Translational Medicine
NeuroscienceNeurologyCognitive Neuroscience
2008English

Ketamine for Depression: Evidence, Challenges and Promise

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2015English

The Promise and Failures of Epigenetic Therapies for Cancer Treatment

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2014English

The Cardiovascular Effects of GLP-1 Receptor Agonists

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2010English

The Protective Effects of Pre-Treatment With Glutamate Metabotropic Receptor Agonists on the Development of Parkinsonian Movements

2011English

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy